Home/Filings/4/0001209191-14-051646
4//SEC Filing

Insys Therapeutics, Inc. 4

Accession 0001209191-14-051646

CIK 0001516479operating

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:41 PM ET

Size

5.3 KB

Accession

0001209191-14-051646

Insider Transaction Report

Form 4
Period: 2014-08-07
BAKER DARRYL S
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-08-07+45,00045,000 total
    Exercise: $27.14Exp: 2024-08-06Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on August 7, 2018.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001516479

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:41 PM ET
Size
5.3 KB